HOB Biotech (China) Performance
| 688656 Stock | 110.10 0.10 0.09% |
HOB Biotech holds a performance score of 29 on a scale of zero to a hundred. The company owns a Beta (Systematic Risk) of 1.16, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, HOB Biotech will likely underperform. Use HOB Biotech Group downside deviation, information ratio, and the relationship between the semi deviation and coefficient of variation , to analyze future returns on HOB Biotech Group.
Risk-Adjusted Performance
29 of 100
Weak | Strong |
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in HOB Biotech Group are ranked lower than 29 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HOB Biotech sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0036 | Payout Ratio 0.7143 | Forward Dividend Rate 0.4 | Ex Dividend Date 2024-06-14 |
1 | Following recent decline, HOB Biotech Group Corp.,Ltds top shareholder CEO John Li sees holdings value drop by 12 percent - Simply Wall St | 12/02/2024 |
| Begin Period Cash Flow | 153.3 M |
HOB |
HOB Biotech Relative Risk vs. Return Landscape
If you would invest 2,261 in HOB Biotech Group on September 13, 2024 and sell it today you would earn a total of 8,749 from holding HOB Biotech Group or generate 386.95% return on investment over 90 days. HOB Biotech Group is generating 3.1313% of daily returns and assumes 8.2617% volatility on return distribution over the 90 days horizon. Simply put, 73% of stocks are less volatile than HOB, and 38% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
HOB Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for HOB Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HOB Biotech Group, and traders can use it to determine the average amount a HOB Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.379
| Best Portfolio | Best Equity | |||
| Good Returns | 688656 | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 8.26 actual daily | 73 73% of assets are less volatile |
Expected Return
| 3.13 actual daily | 62 62% of assets have lower returns |
Risk-Adjusted Return
| 0.38 actual daily | 29 71% of assets perform better |
Based on monthly moving average HOB Biotech is performing at about 29% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HOB Biotech by adding it to a well-diversified portfolio.
HOB Biotech Fundamentals Growth
HOB Stock prices reflect investors' perceptions of the future prospects and financial health of HOB Biotech, and HOB Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HOB Stock performance.
| Return On Equity | 0.0439 | ||||
| Return On Asset | 0.0266 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 6.78 B | ||||
| Shares Outstanding | 63.06 M | ||||
| Price To Book | 8.61 X | ||||
| Price To Sales | 17.30 X | ||||
| Revenue | 394.41 M | ||||
| Gross Profit | 320.16 M | ||||
| EBITDA | 78.62 M | ||||
| Net Income | 47.92 M | ||||
| Total Debt | 54.83 M | ||||
| Book Value Per Share | 12.95 X | ||||
| Cash Flow From Operations | 102.69 M | ||||
| Earnings Per Share | 0.56 X | ||||
| Total Asset | 949.26 M | ||||
| Retained Earnings | 162.13 M | ||||
About HOB Biotech Performance
By analyzing HOB Biotech's fundamental ratios, stakeholders can gain valuable insights into HOB Biotech's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if HOB Biotech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if HOB Biotech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
HOB Biotech is entity of China. It is traded as Stock on SHG exchange.Things to note about HOB Biotech Group performance evaluation
Checking the ongoing alerts about HOB Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HOB Biotech Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| HOB Biotech Group is way too risky over 90 days horizon | |
| HOB Biotech Group appears to be risky and price may revert if volatility continues | |
| HOB Biotech Group is unlikely to experience financial distress in the next 2 years | |
| About 78.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Following recent decline, HOB Biotech Group Corp.,Ltds top shareholder CEO John Li sees holdings value drop by 12 percent - Simply Wall St |
- Analyzing HOB Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HOB Biotech's stock is overvalued or undervalued compared to its peers.
- Examining HOB Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HOB Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HOB Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HOB Biotech's stock. These opinions can provide insight into HOB Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for HOB Stock analysis
When running HOB Biotech's price analysis, check to measure HOB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HOB Biotech is operating at the current time. Most of HOB Biotech's value examination focuses on studying past and present price action to predict the probability of HOB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HOB Biotech's price. Additionally, you may evaluate how the addition of HOB Biotech to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |